Management of Malassezia-related diseases in the dog.
Most cases of Malassezia dermatitis/otitis in the dog are associated with concurrent dermatoses or systemic diseases and recurrences are not uncommon. Recognition and control of the predisposing factors are therefore key factors for successful therapy and prevention of recurrent infections. Currently, Malassezia dermatitis/otitis is managed by the use of antifungal drugs. Systemic therapy is often necessary, in particular when clinical signs are severe and widespread. Ketoconazole and Itraconazole are the most commonly used drugs. Topical therapy is an alternative in case of localized lesions and external ear localizations. Different commercial formulations, available in clinical practice in form of creams, gels, lotions, sprays and ear drops are often used as adiuvants to systemic therapy. Topicals more frequently used are represented by imidazolic antifungals, chlorhexydine and lime sulphur. The presentation deals with more recent advances about the protocols for treatment of Malassezia-related diseases in the dog. New perspectives, as the use of natural compounds, immunotherapy and inhibitors of yeast adherence factors, are also discussed.
Peano
A
A
Dipartimento Produzioni Animali, Epidemiologia ed Ecologia, Università degli Studi di Torino, Italy. andrea.peano@unito.it
Gallo
M G
MG
D000818:Animals; D000935:Antifungal Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D015897:Comorbidity; D003881:Dermatomycoses / Q000188:drug therapy / Q000382:microbiology / Q000628:therapy / Q000662:veterinary*; D004198:Disease Susceptibility; D004283:Dog Diseases / Q000188:drug therapy / Q000382:microbiology / Q000628:therapy*; D004285:Dogs; D006969:Hypersensitivity, Immediate / Q000150:complications / Q000628:therapy / Q000662:veterinary; D008290:Malassezia / Q000302:isolation & purification*; D010032:Otitis Externa / Q000188:drug therapy / Q000382:microbiology / Q000628:therapy / Q000662:veterinary*; D012867:Skin / Q000382:microbiology
D000935:Antifungal Agents